EUVIMEDEUVIMED entdecken
Crossref

N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination

Chengquan Shen, Jing Liu, Fei Xie, Yongbo Yu, Xiaocheng Ma, Ding Hu, Changxue Liu, Yonghua Wang

Cancer Letters · 2024-07 · 595 · 217002

DOI: 10.1016/j.canlet.2024.217002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024-07. Verfasst von Chengquan Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Ubiquitination, Tumor Suppressor Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism underlying N6-methyladenosine (m6A) modification in bladder cancer (BC) remains elusive. We identified that the RBM15/METTL3 complex enhances m6A modification and promotes the ENO1 protein translation efficiency through its 359A site by depending on YTHDF1 in BC cells. In the tumor microenvironment, TGF-β effectively stimulates RBM15/METTL3 expression to improve ENO1 mRNA m6A modification through the Smad2/3 pathway. Reduced ENO1 m6A levels hamper tumor proliferation both in vitro and in vivo. Mechanistically, ENO1 augments PCNA protein stability by reducing its K48-linked ubiquitination and thus prevents protein degradation through the endoplasmic reticulum-associated degradation pathway. According to the subsequent experiments, the ENO1 inhibitor significantly reduced tumor proliferation both in vitro and in vivo. Our study highlights the significance of RBM15/METTL3 complex-mediated ENO1 mRNA m6A modification in ENO1 expression. It also reveals a novel mechanism by which ENO1 promotes BC progression, thereby suggesting that ENO1 can be a therapeutic target for BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsUbiquitinationTumor Suppressor ProteinsDNA-Binding ProteinsAdenosinePhosphopyruvate HydrataseDisease ProgressionCell ProliferationRNA-Binding ProteinsHumansAnimalsCell Line, TumorMiceMethyltransferasesGene Expression Regulation, NeoplasticProtein BiosynthesisMice, NudeBiomarkers, TumorProliferating Cell Nuclear Antigen

Stichwörter der Autor:innen

Bladder cancerENO1N6-methyladenosineRBM15/METTL3

Substanzen

Tumor Suppressor ProteinsENO1 protein, humanN-methyladenosineDNA-Binding ProteinsAdenosinePhosphopyruvate HydrataseRNA-Binding ProteinsPCNA protein, humanMethyltransferasesMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Research Management and International Cooperation, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Qingdao Clinical Medical Research Center for Urinary System Diseases, Qingdao, Shandong, China; Shandong Province Medical a…

Förderung

  • Taishan Scholar Foundation of Shandong Province
  • Taishan Scholar Project of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Shen, C., Liu, J., Xie, F., Yu, Y., Ma, X., Hu, D., Liu, C., & Wang, Y. (2024). N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination. Cancer Letters, 595, 217002. https://doi.org/10.1016/j.canlet.2024.217002

Vancouver

Shen C, Liu J, Xie F, Yu Y, Ma X, Hu D, et al. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination. Cancer Letters. 2024;595:217002. doi:10.1016/j.canlet.2024.217002

BibTeX
@article{Shen2024,
  author = {Shen, Chengquan and Liu, Jing and Xie, Fei and Yu, Yongbo and Ma, Xiaocheng and Hu, Ding and Liu, Changxue and Wang, Yonghua},
  title = {N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination},
  journal = {Cancer Letters},
  year = {2024},
  volume = {595},
  pages = {217002},
  doi = {10.1016/j.canlet.2024.217002}
}
Kostenlos starten →